Reversibility and developmental neuropathology of linear nevus sebaceous syndrome caused by dysregulation of the RAS pathway
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ye Eun | - |
dc.contributor.author | Kim, Yong-Seok | - |
dc.contributor.author | Lee, Hee-Eun | - |
dc.contributor.author | So, Ki Hurn | - |
dc.contributor.author | Choe, Youngshik | - |
dc.contributor.author | Suh, Byung-Chang | - |
dc.contributor.author | Kim, Joung-Hun | - |
dc.contributor.author | Park, Sang Ki | - |
dc.contributor.author | Mathern, Gary W. | - |
dc.contributor.author | Gleeson, Joseph G. | - |
dc.contributor.author | Rah, Jong-Cheol | - |
dc.contributor.author | Baek, Seung Tae | - |
dc.date.accessioned | 2023-08-16T09:28:57Z | - |
dc.date.available | 2023-08-16T09:28:57Z | - |
dc.date.created | 2023-02-10 | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 2211-1247 | - |
dc.identifier.uri | http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/162 | - |
dc.description.abstract | Linear nevus sebaceous syndrome (LNSS) is a neurocutaneous disorder caused by somatic gain-of-function mutations inKRASor HRAS. LNSS brains have neurodevelopmental defects, including cerebral defects and epilepsy; however, its pathologicalmechanism and potentials for treatment are largely unclear.We show that introduction of KRASG12V in the developing mouse cortex results in subcortical nodular heterotopia and enhanced excitability, recapitulating major pathological manifestations of LNSS. Moreover, we show that decreased firing frequency of inhibitory neurons without KRASG12V expression leads to disrupted excitation and inhibition balance. Transcriptional profiling after destabilization domain-mediated clearance of KRASG12V in human neural progenitors and differentiating neurons identifies reversible functional networks underlying LNSS. Neurons expressing KRASG12V show molecular changes associated with delayed neuronal maturation, most of which are restored by KRASG12V clearance. These findings provide insights into the molecular networks underlying the reversibility of some of the neuropathologies observed in LNSS caused by dysregulation of the RAS pathway. | - |
dc.publisher | Cell Press | - |
dc.title | Reversibility and developmental neuropathology of linear nevus sebaceous syndrome caused by dysregulation of the RAS pathway | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choe, Youngshik | - |
dc.contributor.affiliatedAuthor | Rah, Jong-Cheol | - |
dc.identifier.doi | 10.1016/j.celrep.2023.112003 | - |
dc.identifier.scopusid | 2-s2.0-85146260579 | - |
dc.identifier.wosid | 000964720900001 | - |
dc.identifier.bibliographicCitation | Cell Reports, v.42, no.1, pp.112003 | - |
dc.relation.isPartOf | Cell Reports | - |
dc.citation.title | Cell Reports | - |
dc.citation.volume | 42 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 112003 | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | SOMATIC MUTATIONS | - |
dc.subject.keywordPlus | EPILEPSY | - |
dc.subject.keywordPlus | NEURONS | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | PLASTICITY | - |
dc.subject.keywordPlus | EXCITATION | - |
dc.subject.keywordPlus | STABILITY | - |
dc.subject.keywordPlus | STRINGTIE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
61, Cheomdan-ro, Dong-gu, Daegu, Republic of Korea , 41062 053-980-8114
COPYRIGHT Korea Brain Research Institute. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.